Abstract

BACKGROUND AND AIM: (RNA interference) is a new strategy in gene therapy and biotechnology which provides new viewpoints in treatment of different diseases such as cancer and viral disease s. CCND1 which is a key gene in cell cycle is amplified and over expressed in es ophageal cancer. The aim of this study was to produce siRNAs for CCND1, the key gene in cell cycle. METHODS: dsRNA digestion method was applied by using recombinant human dicer enzyme to cleave in vitro transcribed dsRNA i nto a pool of 22bp siRNA. Total RNA was extracted and cDNA was produced using RT-PCR. T7 promoter was added to both ends of the DNA template by PCR. RNA was produced from both strands of the DNA using T7 RNA polymerase. After annealing both strands, dsRNA was prepared. Finally siRNA pool was produced by dicer treatment . RESULTS: RNA extraction yield from HN5 cell line was 14.69 µ g/10 6 cell. The results from beta actin control gene confirmed the cDNA integrity. After optimization, T7 promoter adding was confirmed using gel electrophoresis and DNA sequencing. After optimization dsRNA yield was improved. The best incubation condition was 18h. Each microgram of dsRNA yielded 0.5 µg siRNA. COCLUSION: dsRNA digestion method includes several steps in which the product of each step is used as the precursor for t he next step. So optimization and increasing the specificity and product yield should be the most important goals of the study, Because the yield of each step has a dir ect relationship with the final product yield namely; siRNA. Optimizing and increasing the yield, dsRNA digestion method could be a rapid, available and pr ofitable method for siRNA generation, and providing large amounts of siRNA.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.